[1]
|
Williams, H. and Arnold, H.D. (1899) The effects of violent and prolonged muscular exercise upon the heart. Philadelphia Medical Journal, 3, 1233-1235.
|
[2]
|
Mathews, S.C., Narotsky, D.L., Berbholt, D.L., et al. (2012) Mortality among marathon runners in the United States, 2000-2009. The American Journal of Sports Medicine, 40, 1495-1500.
doi:10.1177/0363546512444555
|
[3]
|
Webner, D., Duprey, K.M., Drezner, J.A., et al. (2012) Sudden cardiac arrest and death in United States Marathons. Medicine & Science in Sports & Exercise, 44, 1843-1845. doi:10.1249/MSS.0b013e318258b59a
|
[4]
|
Kim, J.H., Malhotra, R., Chiampas, G., et al. (2012) For the RACER Study Group. The New England Journal of Medicine, 366, 130-142. doi:10.1056/NEJMoa1106468
|
[5]
|
Siegel, A.J. (2012) Phaedippides Redux; reducing acute cardiac risk during marathon running. The American Journal of Medicine, 125, 630-635.
doi:10.1016/j.amjmed.2011.11.008
|
[6]
|
Siegel, A.J., Silverman, L.M. and Lopez, M.S. (1980) Creatine kinase elevations in marathon runners: Relationship to training and competition. Yale Journal of Biology and Medicine, 53, 275-279.
|
[7]
|
Kratz, A., Lewandrowski, K.B., Siegel, A.J., et al. (2002) Effect of marathon running on hematological and biochemical laboratory parameters including cardiac markers. American Journal of Clinical Pathology, 118, 856-863.
doi:10.1309/14TY-2TDJ-1X0Y-1V6V
|
[8]
|
Siegel, A.J., Verbalis, J.G., Clement, S., et al. (2007) Hyponatremia in Marathon Runners due to Inappropriate Arginine Vasopressin Secretion. The American Journal of Medicine, 120, 461.e11-461.e17.
|
[9]
|
Saenz, A.J., Lee-Lewandrowsi, E., Wood, M.J., et al. (2006) Measurement of a plasma stroke biomarker panel and cardiac troponin T in marathon runners before and after the 2005 Boston marathon. American Journal of Clinical Pathology, 126, 1-5.
doi:10.1309/D7QUF0HJMCYYYY5A
|
[10]
|
Libby, P. and Crea, F. (2010) Clinical implications of inflammation for cardiovascular primary prevention. European Heart Journal, 31, 777-783.
doi:10.1093/eurheartj/ehq022
|
[11]
|
Siegel, A.J., Stec, J.J., Lipinska, I., et al. (2001) Effect of marathon running on inflammatory and hemostatic markers. American Journal of Cardiology, 88, 35-38.
doi:10.1016/S0002-9149(01)01909-9
|
[12]
|
Kratz, A., Wood, M.J., Siegel, A.J., et al. (2006) Effects of marathon running on platelet activation markers. Direct evidence for in vivo platelet activation. American Journal of Clinical Pathology, 125, 296-300.
|
[13]
|
Albano, A.J., Thompson, P.D. and Kapur, N.K. (2012) Acute coronary thrombosis in Boston marathon runners. The New England Journal of Medicine, 366, 184-185.
doi:10.1056/NEJMc1111015
|
[14]
|
Steering Committee of the Physicians’ Health Study Research Group (1989) Final report on the aspirin component of the ongoing Physicians’ Health Study. The New England Journal of Medicine, 321, 129-135.
doi:10.1056/NEJM198907203210301
|
[15]
|
Hennekens, C.H. and Dalen, J.E. (2013) Aspirin in the treatment and prevention of cardiovascular disease: Past and current perspectives and future directions. The American Journal of Medicine, 126, 373-378.
doi:10.1016/j.amjmed.2012.12.013
|
[16]
|
Grosser, T., Fries, S., Lawson, J.A., et al. (2013) Drug resistance and pseudoresistance: an unintended consequence of enteric coated aspirin. Circulation, 127, 377-385.
doi:10.1161/CIRCULATIONAHA.112.117283
|
[17]
|
Ray, W.A., Murray, K.T., Hall, K., et al. (2012) Azithromycin and risk of cardiovascular death. The New England Journal of Medicine, 366, 1881-1890.
doi:10.1056/NEJMoa1003833
|
[18]
|
Weiler, R., Goldstein, M.A., Beasley, I., et al. (2012) What can we do to reduce the number of tragic cardiac events in sport? British Journal of Sports Medicine, 46, 897-898.
doi:10.1136/bjsports-2012-091252
|
[19]
|
Mohlenkamp, S., Lehmann, N., Breuckmann, F., et al. (2008) Running: The risk of coronary events: Relevance and prognostic relevance of coronary atherosclerosis in marathon runners. European Heart Journal, 29, 1903-1910.
doi:10.1093/eurheartj/ehn163
|
[20]
|
Yared, K. and Wood, M.J. (2009) Is marathon running hazardous to your cardiovascular health? The jury is still out. Radiology, 251, 3-5. doi:10.1148/radiol.2511090041
|
[21]
|
Greche, A.L. (2013) Can intense endurance exercise cause myocardial damage and fibrosis? Current Sports medicine reports. Medicine & Science in Sports & Exercise, 12, 63-69.
|
[22]
|
Marijon, E., Tafflet, M., Celermajer, D.S., Dumas, F., Perier, M.C., Mustafic, H., Toussaint, J.F., Desnos, M., Fieu, M., Benameur, N., LeHeuzey, J.Y., Empana, J.P. and Jouven, X. (2011) Sports-related sudden death in the general population. Circulation, 124, 672-681.
doi:10.1161/CIRCULATIONAHA.110.008979
|
[23]
|
Frieden, T.R. and Berwick, D.M. (2011) The “Million Hearts” initiative—Preventing heart attacks and strokes. The New England Journal of Medicine, 365, e27.
doi:10.1056/NEJMp1110421
|